mardi, 20 juin 2017 12:27

Therachon Receives EMA and FDA Orphan Drug Designation for TA-46 for Achondroplasia

Written by 
Rate this item
(0 votes)
Read 686 times Last modified on mardi, 05 juin 2018 14:04